CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,723 | +22.4% | 467 | 0.0% | 0.00% | – |
| Q2 2023 | $10,391 | +2.7% | 467 | 0.0% | 0.00% | – |
| Q1 2023 | $10,115 | +55.6% | 467 | +45.9% | 0.00% | – |
| Q4 2022 | $6,499 | -27.8% | 320 | -13.0% | 0.00% | – |
| Q3 2022 | $9,000 | +28.6% | 368 | +29.1% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 285 | -14.4% | 0.00% | – |
| Q1 2022 | $7,000 | +133.3% | 333 | +158.1% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 129 | +27.7% | 0.00% | – |
| Q3 2021 | $2,000 | -66.7% | 101 | -60.1% | 0.00% | – |
| Q1 2021 | $6,000 | -98.2% | 253 | -99.0% | 0.00% | -100.0% |
| Q4 2018 | $332,000 | -42.9% | 24,832 | -40.1% | 0.00% | -50.0% |
| Q3 2018 | $581,000 | +16.4% | 41,452 | +30.6% | 0.00% | +33.3% |
| Q2 2018 | $499,000 | -8.6% | 31,751 | -4.4% | 0.00% | -25.0% |
| Q1 2018 | $546,000 | – | 33,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |